V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270017160 | 270010614 | 1.62 | 64.5 | Palliative (P) | 2016-12-11 | 2016-12-11 | CYCLOPHOSPHAMIDE + DACARBAZINE + VINCRISTINE | N | N | 270024105 | CVP R |
| 270017161 | 270010615 | 1.91 | 83.3 | Disease modification (D) | 2015-06-03 | 2015-06-03 | NHL 2003 Gp B COP | 02 | N | 270024115 | IDELALISIB |
| 270017162 | 270010616 | 1.73 | 45 | Not known (9) | 2015-05-12 | 2016-03-07 | CYCLOPHOSPHAMIDE + MESNA | N | N | 270024151 | CHOP |
| 270017163 | 270010618 | 1.82 | 73.5 | Disease modification (D) | 2014-01-31 | 2014-01-31 | MELPHALAN | 02 | N | 270024176 | MELPHALAN |
| 270017164 | 270014958 | 1.73 | null | Curative (C) | 2018-05-24 | 2018-05-29 | TEMOZOLOMIDE | 02 | null | 270024186 | METHOTREXATE INTRATHECAL |
| 270017165 | 270010620 | 1.47 | null | Curative (C) | 2015-10-18 | 2016-02-02 | CHOP - 21 days | N | N | 270024192 | RATHL TRIAL |
| 270017166 | 270010624 | 1.48 | 142 | Neo-adjuvant (N) | 2018-06-05 | 2018-06-12 | BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 02 | N | 270024204 | ECHELON 1 TRIAL |
| 270017167 | 270014962 | 1.78 | 66.199 | null | 2017-03-31 | 2017-04-02 | LENALIDOMIDE | 02 | null | 270024216 | ECHELON 1 TRIAL |
| 270017168 | 270010630 | null | 55.4 | Palliative (P) | 2017-03-05 | 2017-06-19 | ECHELON 1 TRIAL | N | N | 270024270 | DOXORUBICIN |
| 270017169 | 270010632 | 1.64 | 60 | Adjuvant (A) | 2014-12-16 | 2015-01-05 | Carboplatin + Paclitaxel (3 weekly) | N | N | 270024285 | R CODOX-M/ R IVAC |
| 270017170 | 270010632 | 1.8 | 90 | Palliative (P) | 2018-03-16 | 2018-03-19 | CHLVPP PABLOE | 02 | N | 270024285 | CYCLOPHOSPHAMIDE |
| 270017171 | 270010633 | 1.82 | 74 | null | 2014-11-18 | 2015-05-12 | BENDAMUSTINE + RITUXIMAB | N | N | 270024329 | CVP |
| 270017172 | 270010635 | 1.83 | 51.2 | Palliative (P) | 2016-09-06 | 2016-09-06 | PACLITAXEL | N | N | 270024460 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270017173 | 270014968 | 1.62 | 84.45 | Curative (C) | 2014-06-20 | 2014-06-28 | MPT | N | null | 270024461 | CVP |
| 270017174 | 270010638 | 1.6 | 83.3 | T | 2014-03-26 | 2014-04-04 | CVP R | Y | Y | 270024473 | ETOPOSIDE |
| 270017175 | 270010639 | null | 68 | Curative (C) | 2015-05-01 | 2015-06-18 | ECHELON 1 TRIAL | N | N | 270024501 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270017176 | 270010641 | 1.79 | 40.3 | Curative (C) | 2017-09-15 | 2017-10-04 | LACE | 2 | N | 270024510 | ETOPOSIDE |
| 270017177 | 270010644 | null | 102.3 | Curative (C) | 2013-04-22 | 2013-05-15 | BOSUTINIB | N | N | 270024518 | METHOTREXATE INTRATHECAL |
| 270017178 | 270010648 | 1.69 | 58 | Palliative (P) | 2017-01-20 | 2017-01-26 | CARBOPLATIN + GEMCITABINE | N | N | 270024541 | IMATINIB |
| 270017179 | 270010649 | 1.6 | 55.3 | Curative (C) | 2014-03-26 | 2014-03-27 | Bevacizumab + Irinotecan + MdG | 02 | N | 270024564 | CUFOX TRIAL |
| 270017180 | 270017257 | 1.67 | 94 | Curative (C) | 2015-03-05 | 2015-03-20 | Bortezomib +/- Dexamethasone | N | N | 270024596 | ECHELON 1 TRIAL |
| 270017181 | 270010652 | 1.45 | null | Curative (C) | 2017-04-30 | 2017-04-30 | CARBOPLATIN + RT | N | N | 270024611 | DA |
| 270017182 | 270010653 | 1.65 | 91.9 | Curative (C) | 2015-09-14 | 2015-09-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 270024614 | BEAM + FLUDARABINE |
| 270017183 | 270010654 | 1.71 | 66.5 | Palliative (P) | 2017-12-14 | 2017-12-15 | PACLITAXEL | N | null | 270024614 | PACLITAXEL |
| 270017184 | 270010656 | 1.84 | 79.8 | null | 2015-03-11 | 2015-03-11 | Capecitabine + Mitomycin | 02 | N | 270024662 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270017185 | 270014977 | 1.76 | 94 | Neo-adjuvant (N) | 2017-06-08 | 2017-06-08 | CARBOPLATIN + RT | N | N | 270024705 | DOCETAXEL |
| 270017186 | 270018556 | 1.7 | 62 | Curative (C) | 2015-09-16 | 2015-09-16 | IBRUTINIB | N | null | 270024741 | DOCETAXEL |
| 270017187 | 270010663 | 1.83 | 92.1 | Palliative (P) | 2018-02-19 | 2018-02-25 | Docetaxel | N | N | 270024754 | CETUXIMAB + CISPLATIN + FU |
| 270017188 | 270010665 | 1.84 | 66.7 | null | 2017-11-20 | 2018-01-16 | Docetaxel | N | N | 270024769 | CAPECITABINE + CARBOPLATIN |
| 270017189 | 270010669 | null | 93.6 | Curative (C) | 2018-11-08 | 2018-12-19 | CAPECITABINE + CETUXIMAB | N | N | 270024790 | CETUXIMAB + MDG |
| 270017190 | 270010673 | 1.63 | 142 | Curative (C) | 2019-01-06 | 2019-01-06 | Hydroxycarbamide | N | N | 270024801 | FLUOROURACIL + RT |
| 270017191 | 270010673 | 1.75 | 83.2 | Palliative (P) | 2012-09-05 | 2014-07-10 | CARBOPLATIN + FLUOROURACIL | N | N | 270024801 | CARBOPLATIN + RT |
| 270017192 | 270014983 | 1.8 | 68 | Adjuvant (A) | 2017-01-09 | 2017-01-09 | Docetaxel 75mg/m2 (21 day) | N | N | 270024824 | SCOT TRIAL |
| 270017193 | 270014984 | null | 73.2 | Palliative (P) | 2015-11-09 | 2015-11-12 | CARBOPLATIN + RT | 02 | N | 270024867 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270017194 | 270010678 | null | 54.9 | Curative (C) | 2018-06-03 | 2018-07-05 | LENALIDOMIDE | N | N | 270024883 | BEVACIZUMAB + CAPE + IRINOTECAN |
| 270017195 | 270014985 | 1.57 | 63.4 | Palliative (P) | 2018-09-11 | 2018-09-15 | RUXOLITINIB | 02 | N | 270024883 | BENDAMUSTINE + CYTARABINE + RITUXIMAB |
| 270017196 | 270010681 | 1.57 | null | Curative (C) | 2017-04-18 | 2018-01-12 | Raltitrexed | N | null | 270024893 | CARBOPLATIN + RT |
| 270017197 | 270017266 | 1.78 | 66.6 | Palliative (P) | 2017-05-25 | 2017-06-02 | Carbo F | 2 | N | 270024900 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 270017198 | 270010684 | 1.96 | null | Palliative (P) | null | 2013-11-16 | Docetaxel 75mg/m2 (21 day) | null | null | 270024923 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270017199 | 270019725 | 1.62 | 55 | Curative (C) | 2014-05-30 | 2014-06-17 | CARBOPLATIN + RT | 2 | N | 270024930 | FEC |
| 270017200 | 270010685 | 1.78 | null | Curative (C) | 2018-02-18 | 2018-03-10 | BLEOMYCIN | N | N | 270024984 | GEMCITABINE + VINORELBINE |
| 270017201 | 270010686 | null | null | Curative (C) | 2014-05-18 | 2015-05-22 | Capecitabine (14 days)+Carboplatin | null | N | 270025032 | CARBOPLATIN + CETUXIMAB + FU |
| 270017202 | 270014989 | 1.66 | 59.7 | Curative (C) | 2018-04-01 | 2018-04-01 | Mitomycin Intravesical | 02 | N | 270025071 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 270017203 | 270014990 | 1.65 | 75 | Palliative (P) | 2017-09-03 | 2017-09-05 | CARBOPLATIN + PACLITAXEL | N | N | 270025074 | TRASTUZUMAB |
| 270017204 | 270010693 | 1.76 | 70 | Curative (C) | 2018-02-03 | 2018-02-24 | CARBOPLATIN + RT | N | null | 270025100 | DOCETAXEL |
| 270017205 | 270010694 | 1.69 | 56.4 | Curative (C) | 2016-09-01 | 2016-09-12 | GemCarbo Days 1+8 | N | N | 270025100 | CARBOPLATIN + CETUXIMAB + FU |
| 270017206 | 270014992 | 1.73 | 0 | null | 2014-05-09 | 2014-10-24 | CARBOPLATIN + RT | N | N | 270025111 | CARBOPLATIN + RT |
| 270017207 | 270010697 | 1.76 | null | Curative (C) | 2013-10-27 | 2013-12-06 | Paclitaxel 7 day | N | N | 270025117 | BEAM + FLUDARABINE |
| 270017208 | 270010701 | 1.73 | 92.2 | Palliative (P) | 2016-12-03 | 2016-12-29 | Bevacizumab + Capecitabine | N | N | 270025137 | MPV |
| 270017209 | 270018562 | 1.72 | 97.3 | Curative (C) | 2015-12-05 | 2016-01-15 | CAPECITABINE + CETUXIMAB | N | N | 270025137 | FEC |